无症状中重度主动脉瓣狭窄患者的运动试验
回顾性队列研究纳入316例中重度主动脉瓣狭窄患者,在专科瓣膜门诊行超声心动图及改良Bruce方案平板运动试验。运动试验安全且耐受良好,未发生严重不良事件;基线运动试验揭示症状者占29%,且重度狭窄显著高于中度;随访期间系列运动试验可揭示症状并提供增量预后信息。
要点
- 中重度主动脉瓣狭窄患者行平板运动试验安全,未观察到严重不良事件。
- 基线运动试验揭示症状在重度狭窄中较中度更常见(38%比23%)。
- 系列运动试验可揭示病史未主动报告的症状,并提供增量预后信息。
核心结论
- 中重度主动脉瓣狭窄患者行运动平板试验安全且耐受良好。
- 系列运动试验有助于揭示病史中未主动报告的症状,并在基线试验基础上提供增量预后信息。
研究设计与样本
- 回顾性队列研究,纳入316例在中重度主动脉瓣狭窄患者在专科瓣膜门诊行超声心动图及改良Bruce方案平板运动试验。
- 患者年龄65±12岁,67%为男性;基线时中度狭窄210例(66%),重度狭窄106例(34%)。
- 结局指标为主动脉瓣置换、全因死亡或主动脉瓣置换与全因死亡的复合终点。
主要发现
- 共发生264例(83%)事件;234例(74%)达到主动脉瓣置换指征,中度狭窄145例(69%),重度狭窄88例(83%)(p<0.05)。
- 随访期间记录30例(9%)死亡,其中20例(67%)为心血管相关死亡。
- 共完成797次运动试验(每人平均2.5±2.1次),未观察到严重不良事件。
- 基线运动试验揭示症状的患病率为29%(n=91),重度狭窄显著高于中度狭窄(38%比23%,p=0.008)。
- 随访34.9(SD 35.1)个月期间系列运动试验中,18%-59%的患者揭示症状;24个月无事件生存率在有揭示症状者为46%±4%,无揭示症状者为70%±4%。
临床怎么用
- 对看似无症状的中重度主动脉瓣狭窄患者,可考虑行平板运动试验以安全地揭示症状。
- 系列运动试验有助于发现病史未主动报告的症状,并可在基线试验基础上提供增量预后信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the safety and tolerability of treadmill exercise testing and the association of revealed symptoms with outcome in apparently asymptomatic patients with moderate to severe aortic stenosis (AS). METHODS: A retrospective cohort study of 316 patients (age 65±12 years, 67% men) with moderate and severe AS who underwent echocardiography and modified Bruce exercise treadmill tests (ETTs) at a specialist valve clinic. The outcome measures were aortic valve replacement (AVR), all-cause mortality or a composite of AVR and all-cause mortality. RESULTS: At baseline, there were 210 (66%) patients with moderate and 106 (34%) with severe AS. There were 264 (83%) events. 234 (74%) patients reached an indication for AVR, 145 (69%) with moderate and 88 (83%) with severe AS (p<0.05). Of the 30 (9%) deaths recoded during follow-up, 20 (67%) were cardiovascular related. In total, 797 exercise tests (mean 2.5±2.1 per patient) were performed. No serious adverse events were observed. The prevalence of revealed symptoms at baseline ETT was 29% (n=91) and was significantly higher in severe AS compared with moderate AS (38%vs23%, p=0.008). Symptoms were revealed in 18%-59% of patients during serial ETT conducted over a follow-up period of 34.9 (SD 35.1) months. The event-free survival at 24 months with revealed symptoms was 46%±4% and without revealed symptoms was 70%±4%. CONCLUSIONS: ETT in patients with moderate or severe AS is safe and tolerable. Serial exercise testing is useful to reveal symptoms not volunteered on the history and adds incremental prognostic information to baseline testing.
引用
- Saeed S, Rajani R, Seifert R, et al. Exercise testing in patients with asymptomatic moderate or severe aortic stenosis. Heart. 2018. PMID: 29654094. doi:10.1136/heartjnl-2018-312939
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。